Application 206633
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACYCLOVIR | ACYCLOVIR | OINTMENT;TOPICAL | 5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206633-001 | ACYCLOVIR | ACYCLOVIR | 5% | OINTMENT / TOPICAL | AB | 2016-05-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206633-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206633-001 | ACYCLOVIR | 5% | OINTMENT / TOPICAL | AB | 2016-05-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206633-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 86c43bdf-c5bf-47cd-8dfd-811263825878 | 2026-07-24 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 736679be-469e-4bdb-8e15-b10751c3dd60 | 2026-07-24 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 38547daa-7d2f-4a7b-84d3-6e164984f958 | 2026-07-17 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Major Pharmaceuticals | 9b254eed-8ea1-469b-bf27-f5670cd99e8d | 2026-07-14 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | ATLANTIC BIOLOGICALS CORP. | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 2026-07-10 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 85332671-0e3a-4445-a337-e1266886b9cf | 2026-07-08 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 499c6a98-0614-4ded-8526-909942bae8a4 | 2026-06-26 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 37a51d9c-1f39-4065-8c7d-6528ac6de91c | 2026-06-23 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Alembic Pharmaceuticals Inc. | 878615c2-09ea-44ce-8c30-7a7f16acb20c | 2026-06-18 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | db35fce0-d7a3-4589-ba60-d78cdb1119cb | 2026-06-18 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Redpharm Drug | 53cbca4d-3ddc-b11e-e063-6394a90a04fa | 2026-06-09 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | St. Mary's Medical Park Pharmacy | 1493e22d-455d-b613-e063-6294a90afede | 2026-06-04 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | dbdb7903-0991-413d-b1ad-ab0f1ae2d8f4 | 2026-06-04 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | db0a0ce5-dc39-4bd3-8b97-21ce9c9999f0 | 2026-05-27 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | 2b600b5d-ce91-461f-b9d1-75b969daf8e9 | 2026-05-21 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 0e78d5e8-ae2d-4e84-b8c2-6765b1299c12 | 2026-05-21 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Cardinal Health 107, LLC | 4cc7d67f-35fa-4238-a581-4810645083cf | 2026-05-14 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Westminster Pharmaceuticals, LLC | f352a641-988e-4878-8016-2b69cd6ee548 | 2026-05-11 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Major Pharmaceuticals | 864d96b9-e2de-45a8-850b-6f7b72ceefe1 | 2026-05-04 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0825 | acyclovir | acyclovir | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0825 | acyclovir | acyclovir | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0825 | acyclovir | acyclovir | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |